Research Article

Evaluating Adherence to Antiretroviral Therapy Using Pharmacy Refill Records in a Rural Treatment Site in South Africa

Table 3

Association between cART adherence and selected sociodemographic and clinical risk factors.

Variable⁢Number (%) of patientsUnadjusted OR (95% CI)Adjusted OR (95% CI)
AdherentNonadherent

Sex
 Male 73 (34.8) 82 (42.9)Referent
 Female137 (65.2)109 (57.1)1.412 1.398 (0.924–2.113)
Age group (years)
 ≤35 87 (41.4)88 (46.1)Referent
 36–45 72 (34.3)63 (33.0)1.156 (0.737–1.812)
 ≥4551 (24.3)40 (20.9)1.290 (0.775–2.146)
Duration under cART (days)
 ≤365 93 (44.3) 70 (36.6)Referent
 ≥365117 (55.7)121 (63.4)0.728 (0.487–1.087)
WHO
 Stage 113 (6.2)13 (7.2)Referent
 Stage 2 81 (38.8) 71 (39.4)1.141 (0.496–2.622)
 Stage 3 79 (37.8) 78 (43.3)1.013 (0.442–2.323)
 Stage 4 36 (17.2) 18 (10.0)2.000 (0.770–5.195)
TB prior to registration into care
 TB positive16 (7.6)15 (7.9)Referent
 TB negative194 (92.4)176 (92.1)0.968 (0.465–2.015)
TB at registration into care
 TB positive 8 (3.8)18 (9.4)Referent
 TB negative202 (96.2)173 (90.6)0.381 0.382
TB after registration into care
 TB positive 28 (13.3) 22 (11.5)Referent
 TB negative182 (86.7)169 (88.5)0.846 (0.466–1.536)
Starting cART regimen
 FDC115 (54.8)99 (51.8)Referent
 Other 95 (45.2)92 (48.2)0.889 (0.600–1.317)
Educational
 Primary school/no education36 (35.3)37 (37.8)Referent
 Secondary school or higher66 (64.7)61 (62.2)1.112 (0.625–1.978)

all patients had this variable recorded.
and  .